DSM Capital Partners’s Insulet PODD Stock Holding History

DSM Capital Partners’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-76	Closed	-$17.7K	–	84
2024 Q3	$17.7K	Hold	76	–	–	﹤0.01%	94
2024 Q2	$15.3K	Buy	+76	New	+$13.7K	﹤0.01%	96

Other funds holding PODD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSM Capital Partners's PODD Position: Q4 2024 in Review

DSM Capital Partners sold out of Insulet (PODD) in Q4 2024, closing a stake of 76 shares — an estimated $17.7K sold.

DSM Capital Partners first reported a position in PODD in Q2 2024 and held it in 2 quarters. The position peaked at $17.7K in Q3 2024. 682 funds tracked by Wall St. Rank hold PODD as of Q4 2024.

DSM Capital Partners reported no remaining Insulet position as of Q4 2024 after selling out during the quarter.
DSM Capital Partners sold 76 Insulet shares in Q4 2024, an estimated $17.7K.
DSM Capital Partners first reported a position in Insulet in Q2 2024 and held it in 2 quarters.
DSM Capital Partners's Insulet position peaked at $17.7K in Q3 2024.
682 funds tracked by Wall St. Rank held Insulet as of Q4 2024.

Based on DSM Capital Partners's 13F filing for Q4 2024, filed 31 Jan 2025.